Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2170137-61-6 (free base) |
|---|---|
| Purity | ≥98% |
| Formula | C16H25N5 |
| Formula Wt. | 287.41 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
| Synonym | KB0742, NSC-834161, NSC834161 |
| Appearance | Yellow to brown crystal |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Topoisomerase II inhibitor, RPA modulator.
Respiratory toxin, mitochondrial permeability t...
Glycopeptide, metal ion chelator, induces DNA s...
β-lactam cephalosporin; penicillin binding pro...
Perfluorinated insecticide.
Peptide, protease substrate.
Endogenous quaternary ammonium, required for fa...
5-fluorouracil prodrug, pyrimidine analog; thym...
O-GlcNAcase inhibitor.
Corticosteroid
Piperadine phenothiazine; FIASMA, D1-5, histami...
Impurity of omeprazole
Dihydropyridine; L-type and T-type Ca2+ channel...
Endogenous neuropeptide hormone; somatostatin a...
NSAID; TREK1 K+ potentiator, voltage-gated Na+ ...
Camptothecin derivative; topoisomerase I inhibi...
Anthracycline, DNA intercalator; topoisomerase ...
Prenylflavinoid, derivative of xanthohumol foun...
Endogenous peptide neurotransmitter, involved i...
Endogenous heptapeptide; P2X3 and N-formylpepti...